Aspira Stock Story

AWH

- USA Stock

USD 0.56 0.01 1.82%

Macroaxis Story

While some baby boomers are getting worried about pharmaceutical products space, we are going to concentrate on both, Aspira Womans and Aeon Global as potential mid-run investments. We are going to examine some of the competitive aspects of both Aspira and Aeon Global.

Published over six months ago

View all stories for Aspira Womans | View All Stories

Is Aeon Global more volatile than Aspira Womans Health (NASDAQ:AWH)?

By analyzing existing basic indicators between Aspira Womans and Aeon Global, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Aeon Global with a short position in Aspira Womans. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aspira Womans has an asset utilization ratio of 0.0443 percent. This implies that the company is making $4.43E-4 for each dollar of assets. An increasing asset utilization means that Aspira Womans Health is more efficient with each dollar of assets it utilizes for everyday operations.

Is Aeon Global more volatile than Aspira Womans Health (NASDAQ:AWH)?

Watch out for price decline

Please consider monitoring Aspira Womans on a daily basis if you are holding a position in it. Aspira Womans is trading at a penny-stock level, and the possibility of delisting is much higher compared to other equities. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Aspira Womans stock to be traded above the $1 level to remain listed. If Aspira Womans stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is Aspira Womans's Liquidity

Aspira Womans financial leverage refers to using borrowed capital as a funding source to finance Aspira Womans Health ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Aspira Womans financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Aspira Womans's total debt and its cash.

How does Aspira utilize its cash?

To perform a cash flow analysis of Aspira Womans, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Aspira Womans is receiving and how much cash it distributes out in a given period. The Aspira Womans cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Aspira Womans Net Cash Flow from Operations is most likely to decrease significantly in the upcoming years. The last year's value of Net Cash Flow from Operations was reported at (27.39 Million)

Purchase by Sandford Nicole of 98000 shares of Aspira Womans

Legal trades by Aspira Womans insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Aspira insider trading alert for perchase of common stock by Sandford Nicole, President and CEO, on 17th of May 2022. This event was filed by Aspira Womens Health Inc with SEC on 2022-05-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Another Outlook On Aspira Womans

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Now, let's check Aspira Womans revenue. Based on the latest financial disclosure, Aspira Womans Health reported 5.98 M of revenue. This is 99.92% lower than that of the sector and 99.7% lower than that of the Revenue industry. The revenue for all United States stocks is 99.94% higher than that of Aspira Womans. As for Aeon Global we see revenue of 12.93 M, which is 99.35% lower than that of the null

Sector

2 B

AWH	5.98 Million	0.3
Sector	1.98 Billion	99.05
AGHC	12.93 Million	0.65

Our perspective of the current Aspira Womans rise

The treynor ratio is down to -6.31 as of today. Aspira Womans Health exhibits very low volatility with skewness of -0.52 and kurtosis of 0.71. However, we advise investors to further study Aspira Womans Health technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aspira Womans' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aspira Womans' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Aspira Womans Implied Volatility

Aspira Womans' implied volatility exposes the market's sentiment of Aspira Womans Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Aspira Womans' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Aspira Womans stock will not fluctuate a lot when Aspira Womans' options are near their expiration.

While other companies under the diagnostics & research industry are still a bit expensive, Aspira Womans may offer a potential longer-term growth to stockholders. The inconsistency in the assessment between current Aspira valuation and our trade advice on Aspira Womans is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Aspira Womans.

Editorial Staff

Gabriel Shpitalnik is a Member of Macroaxis Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Aspira Womans Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2022 Macroaxis LLC